315 related articles for article (PubMed ID: 36772862)
1. C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review.
Monti E; Sarto F; Sartori R; Zanchettin G; Löfler S; Kern H; Narici MV; Zampieri S
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):730-744. PubMed ID: 36772862
[TBL] [Abstract][Full Text] [Related]
2. C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction.
Drey M; Sieber CC; Bauer JM; Uter W; Dahinden P; Fariello RG; Vrijbloed JW;
Exp Gerontol; 2013 Jan; 48(1):76-80. PubMed ID: 22683512
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older multimorbid community-dwellers: Results from the ilSIRENTE study.
Landi F; Calvani R; Lorenzi M; Martone AM; Tosato M; Drey M; D'Angelo E; Capoluongo E; Russo A; Bernabei R; Onder G; Marzetti E
Exp Gerontol; 2016 Jun; 79():31-6. PubMed ID: 27015736
[TBL] [Abstract][Full Text] [Related]
4. Plasma C-Terminal Agrin Fragment as an Early Biomarker for Sarcopenia: Results From the GenoFit Study.
Pratt J; De Vito G; Narici M; Segurado R; Pessanha L; Dolan J; Conroy J; Boreham C
J Gerontol A Biol Sci Med Sci; 2021 Nov; 76(12):2090-2096. PubMed ID: 33993303
[TBL] [Abstract][Full Text] [Related]
5. Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function.
Monti E; Tagliaferri S; Zampieri S; Sarto F; Sirago G; Franchi MV; Ticinesi A; Longobucco Y; Adorni E; Lauretani F; Von Haehling S; Marzetti E; Calvani R; Bernabei R; Cesari M; Maggio M; Narici MV
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):794-804. PubMed ID: 36708273
[TBL] [Abstract][Full Text] [Related]
6. Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
Steinbeck L; Ebner N; Valentova M; Bekfani T; Elsner S; Dahinden P; Hettwer S; Scherbakov N; Schefold JC; Sandek A; Springer J; Doehner W; Anker SD; von Haehling S
Eur J Heart Fail; 2015 Dec; 17(12):1283-93. PubMed ID: 26449626
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients.
Marzetti E; Calvani R; Lorenzi M; Marini F; D'Angelo E; Martone AM; Celi M; Tosato M; Bernabei R; Landi F
Exp Gerontol; 2014 Dec; 60():79-82. PubMed ID: 25304331
[TBL] [Abstract][Full Text] [Related]
8. Active older dancers have lower C-terminal Agrin fragment concentration, better balance and gait performance than sedentary peers.
Marcolin G; Franchi MV; Monti E; Pizzichemi M; Sarto F; Sirago G; Paoli A; Maggio M; Zampieri S; Narici M
Exp Gerontol; 2021 Oct; 153():111469. PubMed ID: 34246731
[TBL] [Abstract][Full Text] [Related]
9. Effect of targeted intervention on C-terminal agrin fragment and its association with the components of sarcopenia: a scoping review.
Kumar P; Nayak K; Umakanth S; Girish N
Aging Clin Exp Res; 2023 Jun; 35(6):1161-1186. PubMed ID: 36977974
[TBL] [Abstract][Full Text] [Related]
10. Genes encoding agrin (AGRN) and neurotrypsin (PRSS12) are associated with muscle mass, strength and plasma C-terminal agrin fragment concentration.
Pratt J; Whitton L; Ryan A; Juliusdottir T; Dolan J; Conroy J; Narici M; De Vito G; Boreham C
Geroscience; 2023 Jun; 45(3):1289-1302. PubMed ID: 36609795
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients.
Hettwer S; Dahinden P; Kucsera S; Farina C; Ahmed S; Fariello R; Drey M; Sieber CC; Vrijbloed JW
Exp Gerontol; 2013 Jan; 48(1):69-75. PubMed ID: 22433628
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults.
Fragala MS; Jajtner AR; Beyer KS; Townsend JR; Emerson NS; Scanlon TC; Oliveira LP; Hoffman JR; Stout JR
J Cachexia Sarcopenia Muscle; 2014 Jun; 5(2):139-48. PubMed ID: 24197815
[TBL] [Abstract][Full Text] [Related]
13. Testosterone does not affect agrin cleavage in mobility-limited older men despite improvement in physical function.
Gagliano-Jucá T; Storer TW; Pencina KM; Travison TG; Li Z; Huang G; Hettwer S; Dahinden P; Bhasin S; Basaria S
Andrology; 2018 Jan; 6(1):29-36. PubMed ID: 28950424
[TBL] [Abstract][Full Text] [Related]
14. Circulating C-Terminal Agrin Fragment: A Potential Marker for Sarcopenia Among Type 2 Diabetes.
Racha P; Selvam S; Bose B; Bantwal G; Sambashivaiah S
Indian J Endocrinol Metab; 2022; 26(4):334-340. PubMed ID: 36185967
[TBL] [Abstract][Full Text] [Related]
15. Plasma C-terminal agrin fragment concentrations across adulthood: Reference values and associations with skeletal muscle health.
Pratt J; Motanova E; Pessanha L; Narici M; Boreham C; De Vito G
J Cachexia Sarcopenia Muscle; 2024 Jun; ():. PubMed ID: 38845597
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation.
Scherbakov N; Knops M; Ebner N; Valentova M; Sandek A; Grittner U; Dahinden P; Hettwer S; Schefold JC; von Haehling S; Anker SD; Joebges M; Doehner W
J Cachexia Sarcopenia Muscle; 2016 Mar; 7(1):60-7. PubMed ID: 27066319
[TBL] [Abstract][Full Text] [Related]
17. A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved.
Moreira-Pais A; Ferreira R; Oliveira PA; Duarte JA
Geroscience; 2022 Jun; 44(3):1199-1213. PubMed ID: 34981273
[TBL] [Abstract][Full Text] [Related]
18. The Reference Intervals for Serum C-Terminal Agrin Fragment in Healthy Individuals and as a Biomarker for Renal Function in Kidney Transplant Recipients.
Yu D; Li HX; Liu Y; Ying ZW; Guo JJ; Cao CY; Wang J; Li YF; Yang HR
J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27638235
[TBL] [Abstract][Full Text] [Related]
19. Effects of a One-Year Physical Activity Program on Serum C-Terminal Agrin Fragment (CAF) Concentrations among Mobility-Limited Older Adults.
Bondoc I; Cochrane SK; Church TS; Dahinden P; Hettwer S; Hsu FC; Stafford RS; Pahor M; Buford TW;
J Nutr Health Aging; 2015 Nov; 19(9):922-7. PubMed ID: 26482694
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Sarcopenia Using Biomarkers of the Neuromuscular Junction in Parkinson's Disease.
Karim A; Iqbal MS; Muhammad T; Qaisar R
J Mol Neurosci; 2022 Apr; 72(4):820-829. PubMed ID: 35044622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
